CJ Darcl Logistics has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for a proposed Initial Public Offering.

Building a pharma-ready logistics network: The need for compliance, speed, and scalability

India’s pharmaceutical sector is at a cusp of transformation. Known as the “Pharmacy of the World”, India supplies almost 20 per cent of global generic medicines. The country now ranks 3rd worldwide by volume of production and 14th by value, thereby accounting for around 10 per cent of world’s production by volume and 1.5 per cent by value. But as the demand for high-value drugs, biologics, and vaccines is growing, the Indian pharmaceutical industry must go beyond just manufacturing excellence and address the challenge of logistics by ensuring medicines are transported safely, quickly and efficiently to all parts of the world. A single lapse in storage, a delay in transit, or a gap in regulatory compliance can compromise the efficacy of life-saving drugs. As India aims to grow its pharma exports 10-15 times by 2047, the need for a resilient, future-ready logistics network has never been greater.